Cyberski, Thomas F. http://orcid.org/0000-0001-5774-3241
Singh, Alka http://orcid.org/0000-0003-2273-3398
Korzinkin, Michael
Mishra, Vasudha
Pun, Frank http://orcid.org/0000-0001-8801-6645
Shen, Le
Wing, Claudia
Cheng, Xiangying
Baird, Brandon
Miao, Yuxuan
Elkabets, Moshe http://orcid.org/0000-0001-7740-0473
Kochanny, Sara http://orcid.org/0000-0003-3755-1175
Guo, Wenji
Dyer, Emma
Pearson, Alexander T. http://orcid.org/0000-0003-2801-7456
Juloori, Aditya
Lingen, Mark
Cole, Grayson
Zhavoronkov, Alex http://orcid.org/0000-0001-7067-8966
Agrawal, Nishant
Izumchenko, Evgeny http://orcid.org/0000-0003-3500-5664
Rosenberg, Ari J. http://orcid.org/0000-0001-5908-0939
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01DE027809, R01DE028674, R21DE032833, R21DE032833)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Burroughs Wellcome Fellowship
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 7 December 2023
Accepted: 8 May 2024
First Online: 23 May 2024
Competing interests
: M.K., A.Z. and F.P. are affiliated with InSilico Medicine, a company developing an AI-based end-to-end integrated pipeline for drug discovery and development. The remaining authors declare no competing interests.